Showing results (91-100 of 108) with videos related to
Sort By:
Pageof 11
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic AdenocarcinomaAmro M Abdelrahman, Ajit H Goenka, Roberto Alva-Ruiz, et al.Annals of Surgical Oncology|January 28, 2021
Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched AnalysisBoateng Kubi, Richard Nudotor, Nadege Fackche, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 18, 2022
Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative StudyKevin M Turner, Mackenzie C Morris, Aaron M Delman, et al.Annals of Surgical Oncology|August 24, 2023
Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal MalignancyNolan M Winicki, Shannon N Radomski, Isabella S Florissi, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 12, 2020
The impact of HIPEC <i>vs.</i> EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborativeJennifer L Leiting, Courtney N Day, William S Harmsen, et al.Journal of Surgical Oncology|July 7, 2020
Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathwaysOliver S Eng, Andrew M Blakely, Kelly J Lafaro, et al.Journal of Clinical Medicine|March 14, 2020
Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective ReviewEliza W Beal, Lorena P Suarez-Kelly, Charles W Kimbrough, et al.Annals of Surgical Oncology|April 25, 2019
Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative StudyNikhil V Kotha, Joel M Baumgartner, Jula Veerapong, et al.Clinical Colorectal Cancer|January 25, 2020
What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC CollaborativeRachel M Lee, Mohammad Y Zaidi, Adriana C Gamboa, et al.Annals of Surgical Oncology|July 23, 2020
Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC CollaborativeAdriana C Gamboa, Rachel M Lee, Michael K Turgeon, et al.Pageof 11